Biomarkers & Companion Diagnostics – Interview with John Reddington
The increased demand for targeted therapeutics has prompted oncology drug developers to uncover innovative solutions to new challenges. Fueled by…
Benefits of Data Analytics in Oncology Clinical Research – Interview with Steve Sweeney
With the volume of medical data doubling every 5 years, the challenge has now become how to derive actionable insights…